The search gave it a shock to Breast cancer, was discovered a new molecule that can actually build a variation to treatment, care and particularly for repeat offenders. E ‘was discovered that 71% of women affected by cancer locally advanced HER2-positive, treated with the molecule trastuzumab survived without recurrence, whereas with chemotherapy survived without recurrence merely 56%. The research is Italian, and this can not but is proud of, but there is to tell that it is a win for all Women all parts of the world. The struggle is yet long, but this treatment has gained a fine level for the struggle against cancer.
The learn was known NOAH and is published in The Lancet and was carried out by confirmation. Luca Gianni, director of Medical Oncology 1 Foundation IRCCS National Cancer Institute and co-founder of the Foundation Michelangelo. Every year there are 38 thousand women affected by breast cancer and 8 thousand of them can not build it.
Breast cancer HER2-positive locally advanced kind of cancer is a very assertive that, before they can be operated, requires medication In practice the variation is correctly in this, using the trastuzumab which is an antibody precise for the HER2 receptor and then the chemo, there are far more likely to heal and above all without recurrence, i.e. without the tumor come back.